Pre-renal AKI is the most common cause of acute kidney injury, accounting for approximately 70% of community-acquired and 40% of hospital-acquired cases. [1] It results from decreased renal perfusion with structurally intact kidneys and is rapidly reversible if the underlying cause is corrected promptly — but prolonged hypoperfusion can progress to ischemic acute tubular necrosis (ATN). [2-3]
The following figure illustrates the pathophysiological cascade from reduced perfusion to decreased GFR in pre-renal AKI:
1. History
- Key HPI questions: Oral intake (poor PO, NPO status), vomiting, diarrhea, bleeding (GI, surgical), excessive sweating/burns, polyuria
- Timing: Onset relative to illness, surgery, medication changes, or volume loss events
- Medication review: Recent initiation or dose changes of diuretics, ACE inhibitors/ARBs, NSAIDs, cyclosporine/tacrolimus [1]
- Cardiac symptoms: Dyspnea, orthopnea, edema (heart failure as cause of decreased effective circulating volume)
- Liver disease: Ascites, jaundice, alcohol use (hepatorenal syndrome)
- Sepsis screen: Fever, chills, source of infection
- Baseline kidney function: Prior creatinine values, known CKD
- Urine output: Quantify — oliguria (<0.5 mL/kg/hr for ≥6 hours) is a KDIGO criterion [5]
2. Alarm Features
- Anuria (suggests complete obstruction or severe ATN rather than simple pre-renal)
- Refractory hyperkalemia with ECG changes (peaked T waves, QRS widening, bradycardia) [6-7]
- Pulmonary edema unresponsive to diuretics
- Severe metabolic acidosis (pH <7.1)
- Uremic symptoms: Encephalopathy, pericarditis, bleeding diathesis [8]
- Hemodynamic instability/shock — MAP <65 mmHg despite resuscitation [9]
- Failure to respond to volume challenge within 24–48 hours (suggests intrinsic AKI) [10]
3. Medications
- Common contributors to pre-renal AKI:
- NSAIDs — inhibit prostaglandin-mediated afferent arteriolar dilation [1]
- ACE inhibitors/ARBs — reduce efferent arteriolar tone; hold during severe AKI [11]
- Diuretics — volume depletion; discontinue in suspected pre-renal AKI [10]
- Cyclosporine/tacrolimus — renal vasoconstriction [1]
- Treatments:
- IV isotonic crystalloids (balanced solutions preferred over 0.9% saline) for volume resuscitation [9][12]
- Vasopressors (norepinephrine first-line) if vasoplegia present [9]
- Albumin for cirrhotic patients (1 g/kg, max 100 g/day) [13]
- Contraindicated: Synthetic colloids (hydroxyethyl starch) — increase RRT risk [9]
- Caution: Loop diuretics should not be used to "treat" pre-renal AKI; they are only indicated for volume overload [9][11]
4. Diet
- Acute phase: NPO or clear liquids if actively vomiting; resume oral hydration as tolerated
- Sodium: Avoid excessive restriction in hypovolemic states; restrict in heart failure/cirrhosis-related pre-renal AKI
- Potassium: Restrict dietary potassium if hyperkalemia develops (avoid bananas, oranges, potatoes, tomatoes)
- Protein: Avoid excessive protein loading during AKI; optimize nutritional status without exacerbating uremia [14]
- Hydration: Encourage adequate oral fluid intake once tolerating PO; individualize based on volume status
5. Review of Systems
- GI: Nausea, vomiting, diarrhea, melena, hematemesis (volume loss sources)
- Cardiovascular: Chest pain, dyspnea, orthopnea, lower extremity edema (cardiac causes)
- Neurologic: Confusion, lethargy, asterixis (uremic encephalopathy)
- Musculoskeletal: Muscle pain, dark urine (rhabdomyolysis → can progress to intrinsic AKI)
- Infectious: Fever, dysuria, cough, abdominal pain (sepsis as precipitant)
- Urologic: Hesitancy, weak stream, suprapubic fullness (rule out post-renal)
6. Collateral History and Family History
- Collateral: Confirm medication compliance, recent procedures/surgeries, fluid intake, witnessed blood loss, baseline functional status
- Family history: Polycystic kidney disease, Alport syndrome, or other hereditary nephropathies (less relevant to pre-renal but important for baseline CKD assessment)
- Social context: Alcohol use (cirrhosis risk), recreational drug use, occupational heat exposure, access to fluids
7. Risk Factors
- Advanced age — elderly patients are particularly susceptible due to predisposition to hypovolemia and renal artery atherosclerosis [1]
- Pre-existing CKD — reduced renal functional reserve [15]
- Heart failure — decreased effective circulating volume [1]
- Liver cirrhosis — splanchnic vasodilation, hepatorenal physiology [2]
- Diabetes mellitus — autonomic dysfunction, nephropathy [15]
- Sepsis — most common cause of AKI in ICU (47% of severe AKI cases) [16]
- Perioperative state — anesthesia decreases effective blood volume and MAP [1]
- Polypharmacy — especially combinations of ACEi + diuretics + NSAIDs ("triple whammy") [1]
8. Differential Diagnosis
9. Past Medical History
- CKD — baseline creatinine is essential for staging; reduced reserve increases vulnerability [15]
- Heart failure — both systolic and diastolic dysfunction reduce renal perfusion [1]
- Cirrhosis — hepatorenal physiology; different volume expansion strategy (albumin) [13]
- Diabetes — nephropathy, autonomic neuropathy
- Prior AKI episodes — recurrent AKI increases CKD progression risk [9]
- Surgical history — recent procedures, vascular surgery, cardiac surgery [15]
- Transplant history — calcineurin inhibitor nephrotoxicity
10. Physical Exam
- Vital signs: Tachycardia, hypotension, orthostatic changes (hallmarks of hypovolemia); MAP <65 mmHg is concerning [9]
- Volume assessment:
- Hypovolemia: Dry mucous membranes, poor skin turgor, flat JVP, delayed capillary refill, tachycardia
- Hypervolemia (with decreased effective circulating volume): Elevated JVP, S3 gallop, peripheral edema, ascites, pulmonary crackles
- Skin: Mottling (shock), rash (vasculitis, interstitial nephritis), livedo reticularis (cholesterol emboli)
- Abdomen: Distension/ascites (cirrhosis), palpable bladder (obstruction), tenderness (peritonitis)
- Focused maneuvers: Passive leg raise (fluid responsiveness assessment); point-of-care ultrasound for IVC collapsibility [10]
11. Lab Studies
- Initial labs: BMP (Cr, BUN, K⁺, bicarb), CBC, urinalysis with microscopy, urine electrolytes (Na, Cr for FENa calculation)
- FENa is most reliable in oliguric patients not on diuretics (pooled sensitivity 95%, specificity 91%). In patients on diuretics, FEUrea <35% may be used as an alternative, though its diagnostic accuracy is moderate [18][20-21]
- Monitor: Serial creatinine (q6–12h in acute setting), potassium, bicarbonate, phosphorus, calcium
- Additional if indicated: Lactate (sepsis), CK (rhabdomyolysis), LFTs (hepatorenal), blood cultures
12. Imaging
- Renal ultrasound: Recommended in most patients to rule out obstruction (hydronephrosis); especially important in older males with BPH, patients with pelvic malignancy, or single kidney [14-15]
- Normal-appearing kidneys on ultrasound are expected in pre-renal AKI
- Point-of-care ultrasound (POCUS): IVC diameter and collapsibility to assess volume status and fluid responsiveness; lung ultrasound for B-lines (pulmonary edema) [10]
- CT abdomen/pelvis: If obstruction suspected but ultrasound equivocal; not routinely needed
- Imaging is unnecessary when the clinical picture clearly supports pre-renal etiology with rapid response to volume resuscitation
13. Special Tests
- FENa Calculator
- KDIGO AKI Staging: [5]
- Stage 1: SCr increase ≥0.3 mg/dL within 48h OR 1.5–1.9× baseline; UO <0.5 mL/kg/h for 6–12h
- Stage 2: SCr 2.0–2.9× baseline; UO <0.5 mL/kg/h for ≥12h
- Stage 3: SCr ≥3.0× baseline OR ≥4.0 mg/dL OR initiation of RRT; UO <0.3 mL/kg/h for ≥24h or anuria ≥12h
- Passive leg raise test: Bedside assessment of fluid responsiveness
- Bladder scan: Rule out urinary retention (post-renal cause)
- Novel biomarkers: NGAL, TIMP-2 × IGFBP-7 (Nephrocheck) can identify tubular injury before creatinine rises, but availability is limited [11]
14. ECG
- Indications: Obtain ECG in all AKI patients with K⁺ >6.0 mEq/L or symptoms of hyperkalemia [22]
- Progressive hyperkalemic ECG changes: [6-7]
- Mild (5.5–6.5 mEq/L): Peaked, narrow-based T waves (earliest finding)
- Moderate (6.5–7.5 mEq/L): PR prolongation, P wave flattening/loss
- Severe (7.0–8.0+ mEq/L): QRS widening, bradycardia, junctional rhythms
- Critical (>8.0–10 mEq/L): Sine wave pattern → VF/asystole
- Important caveat: ECG changes have low sensitivity for detecting hyperkalemia and do not correlate reliably with specific potassium levels — treatment decisions should not be based on ECG alone [22]
- Also assess for signs of underlying cardiac disease (ischemia, heart failure) contributing to pre-renal state
The following algorithm outlines ECG-directed management of hyperkalemia:
15. Assessment
- Pre-renal AKI is a functional decline in GFR due to inadequate renal perfusion with preserved tubular function. The hallmark is reversibility with restoration of perfusion. [2-3]
- Severity stratification is based on KDIGO staging (see above) and the underlying cause — sepsis-related pre-renal AKI carries higher mortality than simple dehydration [16]
- Typical presentation: Oliguria, rising creatinine, concentrated urine (high osmolality, low UNa), bland sediment, in the setting of an identifiable perfusion insult
- Atypical presentations: Non-oliguric pre-renal AKI (especially with partial volume depletion); elderly patients may present with confusion as the primary symptom
- Key complication: If not corrected within hours to days, pre-renal AKI progresses to ischemic ATN, which has a longer recovery course and higher morbidity/mortality [1][3]
16. Treatment Plan
- Initial stabilization:
- Assess and correct hemodynamics — target MAP ≥65 mmHg (individualize for chronically hypertensive patients) [9]
- Establish IV access; place Foley catheter for accurate urine output monitoring
- Volume resuscitation:
- Buffered crystalloids (lactated Ringer's or Plasma-Lyte) preferred over 0.9% normal saline [9][12]
- Administer fluid boluses (250–500 mL) with reassessment after each; goal is euvolemia, not hypervolemia [12]
- Avoid excessive fluid — fluid overload is independently associated with worse outcomes [12]
- In cirrhosis: Albumin 1 g/kg (max 100 g/day) rather than crystalloid [13]
- In cardiorenal syndrome: Diuresis (not volume loading) to relieve venous congestion [11]
- Medication management:
- Discontinue: NSAIDs, ACEi/ARBs, diuretics, nephrotoxic agents [10-11]
- Dose-adjust all renally cleared medications
- Hyperkalemia management (if present):
- Calcium gluconate 10% IV (cardiac membrane stabilization) for ECG changes
- Insulin + dextrose (10 units regular insulin + 25g D50) for intracellular shift
- Sodium bicarbonate if concurrent acidosis
- Kayexalate/patiromer/SZC for potassium removal
- Treat underlying cause: Antibiotics for sepsis, blood products for hemorrhage, inotropes/vasopressors for cardiogenic shock
- Monitor: Urine output hourly, serial BMP q6–12h, daily weights
17. Disposition
- Admission criteria:
- KDIGO Stage 2 or 3 AKI [14]
- Hemodynamic instability or ongoing volume loss
- Hyperkalemia (K⁺ >6.0 mEq/L) or significant metabolic acidosis
- Oliguria/anuria not responding to initial resuscitation
- Underlying cause requiring inpatient management (sepsis, GI bleed, decompensated heart failure)
- Inability to maintain oral hydration
- Observation: Mild AKI (Stage 1) with improving creatinine after ED fluid resuscitation; stable vitals; able to tolerate PO
- Discharge criteria: Creatinine trending toward baseline, adequate urine output, stable electrolytes, identified and correctable cause, reliable follow-up
- Nephrology consultation triggers: [14]
- Stage 3 AKI or need for RRT
- AKI without clear etiology
- Inadequate response to supportive treatment
- Pre-existing CKD stage 4+
- Suspected intrinsic renal disease (glomerulonephritis, vasculitis)
Indications for renal replacement therapy (dialysis) include refractory hyperkalemia, severe metabolic acidosis, pulmonary edema unresponsive to diuretics, and uremic complications (encephalopathy, pericarditis, bleeding). [8-9]
18. Follow Up / Return Precautions
- Follow-up timing: Repeat BMP within 48–72 hours of discharge for mild pre-renal AKI; PCP or nephrology follow-up within 1–2 weeks
- Return precautions — instruct patients to return for:
- Decreased or absent urine output
- Persistent vomiting/diarrhea with inability to keep fluids down
- Confusion, excessive drowsiness
- Chest pain, severe shortness of breath
- Muscle weakness, palpitations (hyperkalemia symptoms)
- Swelling of legs, face, or abdomen
- Patient counseling:
- Maintain adequate oral hydration, especially during illness
- Avoid NSAIDs (ibuprofen, naproxen) — emphasize this is a common precipitant [1]
- Do not restart held medications (ACEi/ARBs, diuretics) until cleared by physician after creatinine normalizes
- Sick-day rules for patients on ACEi/ARBs/diuretics: hold during dehydrating illness
- Expected recovery: Pre-renal AKI typically resolves within 24–72 hours of adequate volume restoration if caught early. Patients with AKI are at increased long-term risk of CKD (9× pooled risk) and premature death (2× risk), warranting ongoing monitoring of kidney function. [2-3][16]
References
1. Acute Renal Failure. — Thadhani R, Pascual M, Bonventre JV. The New England Journal of Medicine. 1996.
2. Acute Kidney Injury: An Increasing Global Concern. — Lameire NH, Bagga A, Cruz D, et al. Lancet. 2013.
3. Low-Flow Acute Kidney Injury: The Pathophysiology of Prerenal Azotemia, Abdominal Compartment Syndrome, and Obstructive Uropathy. — Molitoris BA. Clinical Journal of the American Society of Nephrology : CJASN. 2022.
4. Acute Kidney Injury. — Marissa Dainton Renal Nursing. 2024.
5. 2012 Clinical Practice Guideline for Acute Kidney Injury. — Katrin Uhlig, Jose Calvo-Broce, Ancet Deo, Amy Earley, Ethan M Balk Kidney Disease: Improving Global Outcomes. 2012.
6. Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. — Cao D, Arens AM, Chow SL, et al. Circulation. 2025.
7. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. — Sandau KE, Funk M, Auerbach A, et al. Circulation. 2017.
8. Extracorporeal Kidney-Replacement Therapy for Acute Kidney Injury. — Gaudry S, Palevsky PM, Dreyfuss D. The New England Journal of Medicine. 2022.
9. Acute Kidney Injury. — Ostermann M, Lumlertgul N, Jeong R, et al. Lancet. 2025.
10. Acute Kidney Injury in Patients with Cirrhosis. — Nadim MK, Garcia-Tsao G. The New England Journal of Medicine. 2023.
11. Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives. — Jentzer JC, Bihorac A, Brusca SB, et al. Journal of the American College of Cardiology. 2020.
12. Fluid Management in Acute Kidney Injury. — Ostermann M, Liu K, Kashani K. Chest. 2019.
13. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. — Flamm SL, Wong F, Ahn J, Kamath PS. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 2022.
14. Acute Kidney Injury: Diagnosis and Management. — Mercado MG, Smith DK, Guard EL. American Family Physician. 2019.
15. Acute Kidney Injury: A Guide to Diagnosis and Management. — Rahman M, Shad F, Smith MC. American Family Physician. 2012.
16. Fenoldopam for Preventing and Treating Acute Kidney Injury. — Esezobor CI, Bhatt GC, Effa EE, Hodson EM. The Cochrane Database of Systematic Reviews. 2024.
17. Urinary Diagnostic Indices in Acute Renal Failure: A Prospective Study. — Miller TR, Anderson RJ, Linas SL, et al. Annals of Internal Medicine. 1978.
18. Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury: A Systematic Review and Meta-Analysis. — Abdelhafez M, Nayfeh T, Atieh A, et al. Clinical Journal of the American Society of Nephrology : CJASN. 2022.
19. Evaluation of Simple Diagnostic Parameters in Acute Kidney Injury in Hospitalized Patients-Diagnostic Recommendations for Non-Nephrologists. — Buckenmayer A, Siebler N, Haas CS. Internal and Emergency Medicine. 2023.
20. Utility of Fractional Excretion of Urea in Acute Kidney Injury With Comparison to Fractional Excretion of Sodium: A Systematic Review and Meta-Analysis. — Abdelhafez MO, Alhroob AA, Abu Hawilla MO, et al. The American Journal of the Medical Sciences. 2024.
21. Assessing the Utility of Fractional Excretion of Urea in Distinguishing Intrinsic and Prerenal Acute Kidney Injury in Hospitalised Patients: A Systematic Review and Meta-Analysis. — Pan HC, Jiang ZH, Chen HY, et al. BMJ Open. 2026.
22. Potassium Disorders: Hypokalemia and Hyperkalemia. — Kim MJ, Valerio C, Knobloch GK. American Family Physician. 2023.
23. The Electrocardiogram in Hyperkalemia. — Steven H. Mitchell, William J. Brady The Electrocardiagram in Emergency and Acute Care. 2023.